InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by COLES N ANTHONY, Director. Director active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 8 reports have been recorded. The latest transaction was filed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
0191 shares0
Common Stock
SEC:0001883850-22-000007·
0191 shares0
Common Stock
SEC:0001883850-22-000007:0·
€2m6,909 shares@ €322.29280.0030% mcap72.3% of flow
Common Stock
SEC:0001237899-21-000022·
€2m6,909 shares@ €322.29280.0030% mcap36.1% of flow
Common Stock
SEC:0001237899-21-000022:0·
€265,525900 shares@ €295.02790.0004% mcap8.6% of flow
Common Stock
SEC:0001708138-21-000061·
€265,525900 shares@ €295.02790.0004% mcap4.3% of flow
Common Stock
SEC:0001708138-21-000061:0·
€588,7222,000 shares@ €294.36120.0008% mcap19.1% of flow
Common Stock
SEC:0001708138-21-000052·
€588,7222,000 shares@ €294.36120.0008% mcap9.6% of flow
Common Stock
SEC:0001708138-21-000052:0·
8 of 8 declarations
About COLES N ANTHONY
Anthony N. Coles is a Director at Regeneron Pharmaceuticals, Inc. He contributes to the governance of the company by providing his expertise and advice to the board of directors. His role involves overseeing operations and ensuring that decisions made are in the best interest of shareholders.
